We provide diagnosis and treatment for benign gynecologic diseases including uterine myoma, uterine adenoma, benign tumors of the ovary, cervical intraepithelial neoplasia, uterine prolapse, and endometriosis; and malignant gynecologic diseases including cervical cancer, ovarian cancer, endometrial cancer, and uterine sarcoma.

We perform 3,600 cases of surgery every year, and of these, 1,830 cases are for benign diseases and 1,770 are for cancer (2014 statistics), which is on the largest scale in Korea. We also run the Minimally Invasive Surgery Center and the Gynecologic Clinical Trial Center to aid in maintaining these statistics.
We have experience of the first single-port surgery in the field of gynecology in the world, and the most cases of uterine-preserving surgery in patients with cervical cancer to maintain pregnancy. Also, we specialize in laparoscopic surgery, and not only perform over 50% of gynecologic cancer surgery with laparoscopic surgery, but also perform robotic surgery for benign and malignant diseases as a leading hospital of robotic surgery in Korea. We are world leaders in the advancement of surgical technique through single-port robotic surgery.
We provide a multi-disciplinary practice for patients with intractable gynecologic malignancies, and personalized medicine through the Ovarian Clear Cell Carcinoma Clinic and Ovarian Cancer Screening Clinic. We also use authorized, targeted therapy for intractable gynecologic malignancies safely and actively, based on our extensive experience through the Gynecologic Clinical Trial Center and the Molecular Target Therapeutics Research Center.
Other advantages of the Department of Obstetrics and Gynecology at the Samsung Medical Center are the rapid treatment process alongside medical care, education, and research, the Patient’s Day celebration to encourage our patients, and the education provided to patients and their caregivers. The Department of Obstetrics and Gynecology at the Samsung Medical Center makes these efforts to become “The One, the Best.”

Special clinics

In the obstetrics (obstetric fetal medicine) part of the Department of Obstetrics and Gynecology at the Samsung Medical Center, a board-certified physician takes exclusive care of the out- and inpatients, and we maintain a system where a board-certified physician can rapidly deal with emergencies in the ward and delivery room 24 hours a day.
The delivery room has space for treating patients in labor, during delivery for surgery, and in obstetric emergencies, as well as for medical devices. In 2015, we changed all labor rooms into single rooms through remodeling, so that the patient can prepare for delivery with their caregiver during labor in a private space. In addition, we have a 24-hour duty system with dedicated anesthesiologists that enables us to perform painless delivery 24 hours a day, and rapid surgical treatment is possible whenever emergency surgery is necessary. Also, in case of post-partum bleeding, which is the most common cause of maternal death, we can perform uterine artery embolism 24 hours a day through emergency collaboration with the Department of Radiology. We have received first class in the relevance evaluation of performed caesarian sections by the Ministry of Health and Welfare every year, and have been commended for having reduced the number of unnecessary procedures and having enhanced patient safety. Particularly in the family delivery room, the mother and her family can participate in all stages of the birth including labor, delivery, and recovery, and there are cutting-edge devices present to monitor the status of the fetus, along with a specially designed bed that allows adjustment during the process of delivery. Also, we possess up-to-date equipment for emergencies including treatment beds for newborns, and various amenities for the convenience of the family including refrigerators, audio systems, TVs, and shower booths.
In the Department of Obstetrics and Gynecology at the Samsung Medical Center, we provide top-class medical service for fetuses and newborns. Since the opening of our hospital, we have implemented rooming-in systems to allow mothers and babies to stay together in our obstetric ward and encouraged mothers to breastfeed their babies. In 1997, our hospital was certified by UNICEF as a "Baby Friendly Hospital." We have the largest team, amongst all the hospitals in Korea, with 20 breastfeeding and infant care experts to help mothers and babies form the most natural and closest relationship. In addition, our neonatal intensive care unit is known for the highest survival rate of pre-term babies and the survival of the smallest pre-term babies in Korea, and works closely with other departments in our Pediatric Adolescent Center.

We perform various ultrasound tests including detailed ultrasonography in early pregnancy, mid-pregnancy, and late pregnancy, and fetal echocardiography, to diagnose various congenital fetal malformations pre-natally. In particular, if a patient is transferred from another hospital with the diagnosis of a fetal congenital heart malformation, detailed ultrasonography performed by a board-certified physician is available on the day of the visit.
We perform comprehensive screening tests for congenital malformations in the first and second trimesters of pregnancy to increase the probability of diagnosing Down syndrome and neural tube defects, and amniotic fluid tests can be performed if necessary. Various other pre-natal tests can be performed for various genetic disorders.

Through the amniopatch procedure, we make efforts to lengthen the duration of pregnancy and enhance the survival rate of the newborn in patients with premature rupture of membranes before 24 weeks of pregnancy.
We possess various fetal treatment technologies and equipment including fetal endoscope, laser therapy, high-frequency ablation, and ex utero intra-partum treatment (EXIT), and perform active treatment for fetal abnormalities that are treatable pre-natally.

We are in the process of conducting placental research to find factors inducing or involved in pre-eclampsia and intra-uterine growth retardation, and are actively participating in this research in the hope of understanding the pathogenesis of these disorders, and to contribute to the prevention and treatment of them in the future. We are also actively participating as a leading institute in the national multi-center clinical study for the prediction and prevention of pre-term delivery, which is the most important cause of death in newborns.